John Chambers, MD
Cardiovascular Disease · Idaho Falls, IDNPI 1578568242
Payments from drug & device makers
Across 478 payments — averaging $16.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Abbott$1K
- Novartis$816
- Edwards Lifesciences$456
- E.r. Squibb & Sons, L.L.C.$337
- Abiomed$276
- plus $1K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 179 | $3,248 |
| Abbott | 75 | $1,436 |
| Novartis | 79 | $816 |
| Edwards Lifesciences | 17 | $456 |
| E.r. Squibb & Sons, L.L.C. | 48 | $337 |
| Abiomed | 10 | $276 |
| Boston Scientific | 15 | $253 |
| AstraZeneca | 4 | $162 |
| Heartflow, Inc. | 3 | $143 |
| Pfizer | 9 | $141 |
| Johnson & Johnson | 8 | $125 |
| Penumbra, Inc. | 3 | $71 |
| Amgen | 3 | $52 |
| Baxter Healthcare | 2 | $44 |
| Lexicon Pharmaceuticals, Inc. | 2 | $42 |
| Tersera Therapeutics LLC | 2 | $40 |
| Acist Medical Systems, Inc. | 1 | $36 |
| Regeneron Healthcare Solutions, Inc. | 2 | $31 |
| GE HealthCare | 1 | $30 |
| Actelion Pharmaceuticals US, Inc. | 2 | $29 |
| Bardy Diagnostics, Inc. | 2 | $28 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $22 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $22 |
| Merck | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Philips North America LLC | 1 | $17 |
| Bayer | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $14 |
| Sunovion Pharmaceuticals Inc. | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$7,974 in reported general payments places this provider in the 80th percentile of 59 cardiovascular disease providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Idaho Falls
- Douglas BlankIdaho Falls$11K
- John LassetterIdaho Falls$6K
- Paul GerlachIdaho Falls$6K
- George GarciaIdaho Falls$6K
- Patrick GormanIdaho Falls$4K
- Ricky LathamIdaho Falls$2K
- Thomas MaleyIdaho Falls$35
- Kim CoffmanIdaho Falls$12
- David HinchmanBoise$1.6M
- Ronald FritzCoeur D Alene$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.